AI Summary
✦ ClarthaValuation Metrics
Trading 33.3% above historical median. Valuation is rising — currently in the strongly overvalued zone (z-score: +1.56). Confidence: 79%.
Live forward EPS implies next-12-month EPS of ₹34.90. Applying the stock's normalized valuation corridor produces a fair range of ₹537.11 to ₹799.91, with base value near ₹690.67 (+17.6% vs current price).
Live forward estimate anchored to the company's historical valuation corridor.
Forward EPS
₹34.90
Forward P/E
16.8x
Base Fair Value
₹690.67
Fair Range
₹537.11 - ₹799.91
Upside To Base
+17.6%
Estimate Source
Live forward EPS
Growth Estimate
+23.0%
5Y Average
17.39
Current
26.38
Overvalued
22.92
Undervalued
15.39
5Y Average
11.03
Current
16.73
Overvalued
13.95
Undervalued
8.71
5Y Average
3.62
Current
3.96
Overvalued
4.16
Undervalued
3.08
Peers & Comparison
Sector: Materials · Theme: Diversified Chemicals
| Company | Rev. Growth | Margin | P/E | vs Avg | 52W Perf. |
|---|---|---|---|---|---|
BASF INDIA LTD BASFDiversified Chemicals | +24.5% | 4.0% | 28.3x Undervalued | -80% vs avg | -13.2% |
TATA CHEMICALS LTD TATACHEMDiversified Chemicals | +14.4% | -14.3% | — | — | -29.2% |
SUDARSHAN CHEMICAL INDS L SUDARSCHEMDiversified Chemicals | +106.7% | 0.2% | 389.5x Premium | +173% vs avg | -21.8% |
DCM SHRIRAM LIMITED DCMSHRIRAMDiversified Chemicals | +9.3% | 10.4% | 11.0x Undervalued | -92% vs avg | -24.4% |
VISHNU CHEMICALS LIMITED trades at a discount (26.4x vs peer avg 142.9x), suggesting potential undervaluation relative to the Diversified Chemicals cohort. Peers include BASF INDIA LTD, TATA CHEMICALS LTD, SUDARSHAN CHEMICAL INDS L — selected based on business model, industry classification, market cap similarity, and business theme alignment.
Financials
Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.
Latest revenue
₹305 CrDec 2025Latest net profit
₹22 CrDec 2025Latest EPS
₹3.25Dec 2025Net margin
9.4%Dec 2025Performance
Bars show revenue and net profit. The line shows net margin.
- Revenue
- Net income
- Net margin %
Earnings
Revenue is shown in crores. EPS is rupees per share.
- Revenue
- EPS
Revenue to profit conversion
Bridge from operating numbers to profit for the latest reported period.
Latest reported period: Dec 2025
Debt level and coverage
Debt, cash and free cash flow compared on the same crore scale.
- Debt
- Free cash flow
- Cash & equivalents
Results
| Metric | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 299 | 250 | 265 | 252 | 243 | 258 | 264 | 280 | 295 | 263 | 305 | 305 |
| Expenses | 242 | 207 | 228 | 219 | 198 | 214 | 233 | 241 | 266 | 231 | 275 | 270 |
| Operating Profit | 52.45 | 37.29 | 31.37 | 27.45 | 39.86 | 37.94 | 25.88 | 33.25 | 23.88 | 25.29 | 23.74 | 28.59 |
| OPM % | 17.54% | 14.92% | 11.83% | 10.87% | 16.4% | 14.7% | 9.79% | 11.88% | 8.09% | 9.63% | 7.79% | 9.37% |
| Other Income | 2.32 | 2.03 | 3.94 | 6.15 | 4.04 | 2.52 | 3.34 | 3.62 | 2.75 | 5.48 | 8.31 | 6.42 |
| Interest | 6.45 | 6.47 | 5.69 | 5.98 | 6.64 | 6.32 | 6.96 | 6.76 | 6.03 | 6.15 | 6.3 | 5.94 |
| Depreciation | 5.04 | 5.28 | 5.37 | 5.59 | 5.52 | 5.85 | 5.89 | 5.87 | 5.73 | 5.89 | 6.09 | 6.17 |
| Profit before tax | 48.32 | 32.85 | 29.62 | 27.62 | 37.26 | 34.14 | 22.26 | 30.11 | 20.6 | 24.62 | 25.75 | 29.07 |
| Tax % | 26.08% | 22.4% | 19.72% | 19.51% | 38.89% | 22.91% | 23.9% | 25.81% | 28.98% | 26.89% | 24.12% | 24.66% |
| Net Profit | 35.72 | 25.49 | 23.78 | 22.23 | 22.77 | 26.32 | 16.94 | 22.34 | 14.63 | 18 | 19.54 | 21.9 |
| EPS in Rs | 5.98 | 4.27 | 3.74 | 3.39 | 3.47 | 4.02 | 2.59 | 3.41 | 2.19 | 2.67 | 2.90 | 3.25 |
All values in Rs. Crore unless otherwise stated. Source: CMIE Prowess, Quarterly Interim Standalone.